EMA confirms full functionality of CTIS - on track to go live January 2022

Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
Last week, the EMA confirmed that the clinical trial EU Portal and Database (Clinical Trial Information System (CTIS)) is now fully functional and on track to go live by 31 January 2022.
This would imply that the Commission notice in the Official Journal would be published on 31 July 2021. The EU Clinical Trial Regulation (CTR EU No 536/2014) will then come into first operation six months after the notice of the full functionality of the CTIS. The CTR aims to harmonise the registration and supervision processes for clinical trials throughout the EU.
When it goes live, the CTIS will be the single EU entry point for clinical trial applications. Clinical trial sponsors will then be able to apply for a clinical trial with one application instead of having to apply separately in every country. The single application will include the submission to national competent authorities and to ethics committees. In addition, instead of the current EU GMP Annex 13 (Manufacture of IMPs), the Detailed Commission guidelines on GMP for IMPs for human use will then apply.
For more information please see EMA´s announcement Clinical Trials Information System reaches major milestone towards go-live and application of the Clinical Trial Regulation.
Related GMP News
07.04.2025EMA's Plans for the next three Years
07.04.2025Q&A Document on QP Declaration updated
02.04.2025Switzerland: Update of the Technical Interpretation on the PQR
02.04.202512th Edition of The International Pharmacopoeia
26.03.2025Securing the Supply of Medicines in the EU through the Critical Medicines Act
19.03.2025Strategic Report published by the Critical Medicines Alliance